J. J. Mazza

1.9k total citations
30 papers, 1.3k citations indexed

About

J. J. Mazza is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. J. Mazza has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. J. Mazza's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). J. J. Mazza is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). J. J. Mazza collaborates with scholars based in United States. J. J. Mazza's co-authors include Steven H. Yale, Florence Aslinia, Dinesh Kumar, Ingrid Glurich, Martin M. Oken, John M. Bennett, John Hines, Heather S. Bonner, Peter A. Cassileth and C B Begg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Thrombosis and Haemostasis.

In The Last Decade

J. J. Mazza

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. J. Mazza United States	15	536	270	246	217	196	30	1.3k
Fatma Gümrük Türkiye	23	817 1.5×	497 1.8×	218 0.9×	179 0.8×	366 1.9×	200	2.0k
Edwin N. Forman United States	19	345 0.6×	224 0.8×	377 1.5×	113 0.5×	86 0.4×	50	1.3k
E. M. Berkman United States	20	565 1.1×	241 0.9×	72 0.3×	156 0.7×	112 0.6×	43	1.1k
Pekka Riikonen Finland	23	352 0.7×	117 0.4×	488 2.0×	744 3.4×	185 0.9×	72	1.8k
Catherine Bagot United Kingdom	18	752 1.4×	138 0.5×	141 0.6×	66 0.3×	274 1.4×	46	2.0k
Richard Soutar United Kingdom	16	871 1.6×	226 0.8×	76 0.3×	394 1.8×	547 2.8×	47	1.5k
Hubert Nivet France	28	439 0.8×	211 0.8×	190 0.8×	59 0.3×	581 3.0×	99	3.1k
Bahattin Tunç Türkiye	16	314 0.6×	149 0.6×	149 0.6×	116 0.5×	88 0.4×	96	866
Hale Ören Türkiye	17	361 0.7×	128 0.5×	118 0.5×	103 0.5×	84 0.4×	114	971
Rebecca Davies United Kingdom	20	481 0.9×	169 0.6×	81 0.3×	70 0.3×	114 0.6×	66	1.2k

Countries citing papers authored by J. J. Mazza

Since Specialization

Citations

This map shows the geographic impact of J. J. Mazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. J. Mazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. J. Mazza more than expected).

Fields of papers citing papers by J. J. Mazza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. J. Mazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. J. Mazza. The network helps show where J. J. Mazza may publish in the future.

Co-authorship network of co-authors of J. J. Mazza

This figure shows the co-authorship network connecting the top 25 collaborators of J. J. Mazza. A scholar is included among the top collaborators of J. J. Mazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. J. Mazza. J. J. Mazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berg, Richard L., et al.. (2014). Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures. Clinical Medicine & Research. 13(1). 1–6. 2 indexed citations

Kumar, Dinesh, et al.. (2010). Virchow's Contribution to the Understanding of Thrombosis and Cellular Biology. Clinical Medicine & Research. 8(3-4). 168–172. 186 indexed citations

Ward, Michael, et al.. (2010). Josef Brudzinski and Vladimir Mikhailovich Kernig: Signs for Diagnosing Meningitis. Clinical Medicine & Research. 8(1). 13–17. 14 indexed citations

Johnson, Sara K., et al.. (2009). Adolf Kussmaul: Distinguished Clinician and Medical Pioneer. Clinical Medicine & Research. 7(3). 107–112. 11 indexed citations

Aslinia, Florence, J. J. Mazza, & Steven H. Yale. (2006). Megaloblastic Anemia and Other Causes of Macrocytosis. Clinical Medicine & Research. 4(3). 236–241. 235 indexed citations

Mazza, J. J., Steven H. Yale, Ingrid Glurich, et al.. (2005). Efficacy of the Influenza Vaccine in Patients with Malignant Lymphoma. Clinical Medicine & Research. 3(4). 214–220. 50 indexed citations

Yale, Steven H., et al.. (2004). Practical Considerations to Influenza Vaccination. Clinical Medicine & Research. 2(4). 256–259. 7 indexed citations

Mazza, J. J., et al.. (1997). Rural Health Care Providersâ Educational Needs Related to Agricultural Exposures. Journal of Agricultural Safety and Health. 3(4). 9 indexed citations

Mazza, J. J., John Hines, Janet W. Andersen, et al.. (1995). Aggressive Chemotherapy in the Treatment of Burkitt's and Non-BurKitt's Undifferentiated Lymphoma. Leukemia & lymphoma. 18(3-4). 289–296. 5 indexed citations

10.

Cassileth, Peter A., J. W. Andersen, John M. Bennett, et al.. (1992). Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.. PubMed. 6 Suppl 2. 178–81. 33 indexed citations

11.

Cassileth, Peter A., Janet W. Andersen, John M. Bennett, et al.. (1992). Escalating the intensity of postremission therapy improves the outcome in acute myeloid leukemia: The ECOG experience. 6. 116–119. 14 indexed citations

12.

Mazza, J. J., et al.. (1992). Hematopoietic growth factors. Postgraduate Medicine. 91(8). 299–312. 3 indexed citations

13.

Raphael, Bruce G., J. W. Andersen, R Silber, et al.. (1991). Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.. Journal of Clinical Oncology. 9(5). 770–776. 97 indexed citations

14.

Mazza, J. J.. (1991). Antithrombin-HI (AT-III) Deficiency Spanning Four Generations. Thrombosis and Haemostasis. 66(6). 737–738. 2 indexed citations

15.

Cassileth, Peter A., David P. Harrington, John Hines, et al.. (1990). Comparison of Postremission Therapies in Adult Acute Myeloid Leukemia: Preliminary Analysis of an ECOG Study. Hämatologie und Bluttransfusion. 33. 267–270. 3 indexed citations

16.

Rowe, Jacob M., J. J. Mazza, John Hines, et al.. (1990). Mitoxantrone and Etoposide in Patients with Relapsed and Refractory Acute Nonlymphocytic Leukemia. Hämatologie und Bluttransfusion. 33. 326–329. 8 indexed citations

17.

Cassileth, Peter A., Donald P. Harrington, John Hines, et al.. (1988). Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.. Journal of Clinical Oncology. 6(4). 583–587. 117 indexed citations

18.

Friedenberg, William R., et al.. (1986). Improved survival in the treatment of advanced hodgkin's disease at a nonuniversity institution (1970–1979). Cancer. 57(1). 12–17. 6 indexed citations

19.

Hines, John, et al.. (1984). High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.. Journal of Clinical Oncology. 2(6). 545–549. 98 indexed citations

20.

Mazza, J. J., et al.. (1977). Quantitative osmotic fragility and disease states: a preliminary study.. PubMed. 89(2). 409–13. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact